Announced today by GSK: VHIO joins five other international research centers of excellence as member of the Oncology Clinical and Translational Consortium (OCTC)

Hosted by VHIO, ecancermedicalscience Editor, Gordon McVie interviews lead authors of a recent study published in The Lancet

  • The BBVA Foundation backs research aimed at preclinically validating recently reported findings that established Omomyc as a potential…

An international phase III study published in the New England Journal of Medicine (NEJM), in which the Vall d’Hebron University…

VHIO Meet the Editors with The New England Journal of Medicine: Monday 14 May 2012

The New England Journal of Medicine´s Bette Phimister, Deputy Editor, will join us to deliver the next in the prestigious series of VHIO Meet the Editors talks:

Publishing Advances in Cancer Research

Bette Phimister will review progress and pitfalls in cancer research and issues concerning its publication, with a focus on targeted therapies and an eye to future developments.

Arkaitz Carracedo, Group Leader of the Cell Signalling and Metabolism in Cancer Group at CIC bioGUNE in the Basque Country…

Inés Gasén was diagnosed with breast cancer during her pregnancy – not only naturally provoking fear and uncertainty for her…

  • The PIM1 proto-oncogene evidenced as new therapeutic target through which to sensitize triple-negative breast tumours to chemotherapy• PIM1…

Source: Merck Serono Merck Serono and Sysmex Inostics Announce First Liquid Biopsy RAS Biomarker Testing Center Opens: Important Milestone for…

Cristina Saura, Principal Investigator of VHIO´s Breast Cancer and Melanoma Group, today reported important findings during her thesis defence directed…

An interview with Ana Vivancos, Principal Investigator of VHIO´s Cancer Genomics Group “We are one of the few groups in…

Published today in the journal Clinical Cancer Research, results from an international multi-center study led by Aleix Prat, Principal Investigator…

IMPORTANT NOTIFICATION: As an update to this earlier news item (see below), Pau´s fundraising concert on the 22nd December is…

Antonio Hurtado, from the Cambridge Research Institute, will offer a seminar on the factors that cause resistance to Tamoxifen on breast cancer patients

Just like any other discipline in oncology, the rapidly emerging radiogenomics landscape is also being shaped by big data, large-scale…

The FC Barcelona Foundation and the Vall d’Hebron Institute of Oncology have signed a collaborative agreement to raise awareness about…